Secretion of oncostatin M by neutrophils in rheumatoid arthritis

被引:60
作者
Cross, A
Edwards, SW
Bucknall, RC
Moots, RJ
机构
[1] Univ Liverpool, Univ Hosp Aintree, Acad Rheumatol Unit, Liverpool L9 7AL, Merseyside, England
[2] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England
来源
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 05期
关键词
D O I
10.1002/art.20166
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective. Neutrophils are known to express and release a large number of proinflammatory cytokines when they are stimulated by inflammatory stimuli. The objective of this study was to determine whether neutrophils express oncostatin M (OSM), a member of the interleukin-6 family of cytokines that has been implicated in the pathogenesis of inflammatory joint disease. Methods. Neutrophils were isolated from the blood of healthy volunteer donors and from the blood and synovial fluid of patients with rheumatoid arthritis (RA). OSM levels were measured in cell extracts and in culture supernatants by Western blotting. Total RNA was isolated from control and granulocyte-macrophage colony-stimulating factor (GM-CSF)-treated neutrophils, and OSM messenger RNA levels were quantified by hybridization of a radiolabeled probe. Results. GM-CSF stimulated a rapid and transient expression and release of OSM from blood neutrophils, which was more rapid than the expression and release from blood monocytes. A 28-kd protein was identified in cell extracts, but an additional 25-kd isoform was detected in culture supernatants. Synovial fluid neutrophils could not be stimulated to express OSM, but this cytokine was detected in cell-free supernatants at various levels. Conclusion. Blood neutrophils can be stimulated to express and rapidly release large quantities of OSM. We propose that this important cytokine is released from neutrophils as they infiltrate rheumatoid joints and, thus, contribute to the complex cytokine network that characterizes RA.
引用
收藏
页码:1430 / 1436
页数:7
相关论文
共 36 条
[1]
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage [J].
Abramson, SB ;
Amin, A .
RHEUMATOLOGY, 2002, 41 (09) :972-980
[2]
ALVAROGRACIA JM, 1991, J IMMUNOL, V146, P3365
[3]
THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[4]
DIFFERENTIAL EXPRESSION OF 2 MAJOR CYTOKINES PRODUCED BY NEUTROPHILS, INTERLEUKIN-8 AND THE INTERLEUKIN-1 RECEPTOR ANTAGONIST, IN NEUTROPHILS ISOLATED FROM THE SYNOVIAL-FLUID AND PERIPHERAL-BLOOD OF PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
BEAULIEU, AD ;
MCCOLL, SR .
ARTHRITIS AND RHEUMATISM, 1994, 37 (06) :855-859
[5]
Bresnihan B, 1999, J RHEUMATOL, V26, P717
[6]
BRUCE AG, 1992, J IMMUNOL, V149, P1271
[7]
Cytokine expression and release by neutrophils [J].
Cassatella, MA ;
Gasperini, S ;
Russo, MP .
PHAGOCYTES: BIOLOGY, PHYSIOLOGY, PATHOLOGY, AND PHARMACOTHERAPEUTICS, 1997, 832 :233-242
[8]
Anti-tumour necrosis factor (TNF)-α therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis [J].
Catrina, AI ;
Lampa, J ;
Ernestam, S ;
af Klint, E ;
Bratt, J ;
Klareskog, L ;
Ulfgren, AK .
RHEUMATOLOGY, 2002, 41 (05) :484-489
[9]
Catterall JB, 2001, ARTHRITIS RHEUM-US, V44, P2296, DOI 10.1002/1529-0131(200110)44:10<2296::AID-ART392>3.0.CO
[10]
2-9